• Exchange: Stockholm
  • Sector: Financials
  • Industry: Asset Management
  • Sub-Industry: Private Equity

Karolinska Development AB

+ Add to Watchlist


14.6000 SEK 0.2500 1.74%

As of 11:29:59 ET on 12/23/2014.

Snapshot for Karolinska Development AB (KDEV)

Open: 14.7000 Day's Range: 14.3000 - 14.7000 Volume: 34,471
Previous Close: 14.3500 52wk Range: 10.2000 - 31.8000 1-Yr Rtn: -50.84%

Stock Chart for KDEV

No chart data available.
  • KDEV:SS 14.6000
  • 1D
  • 1M
  • 1Y
Interactive KDEV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for KDEV

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. OMX -
Earnings Per Share (SEK) (ttm) -9.2600
Est. EPS (SEK) (12/2014) -4.3700
Est. PEG Ratio -
Market Cap (M SEK) 779.41
Shares Outstanding (M) 51.88
30 Day Average Volume 64,291
Price/Book (mrq) 0.4231
Price/Sale (ttm) 104.9863
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/19/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for KDEV

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for KDEV

Karolinska Development AB manages a portfolio of life science companies in Europe. The Company's portfolio companies are focused on pharmaceutical development across a broad range of therapeutic areas. Karolinsk's portfolio also encompasses companies developing theranostics as well as medical and formulation technologies.

Bruno LucidiChief Executive OfficerChristian TangeChief Financial Officer
Terje KallandDeputy CEO/Chief Scientific OfcrUlf RichenbergGeneral Counsel
More Company Profile & Key Executives for KDEV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil